Diabetic eye disease

scientific article published on 01 July 1997

Diabetic eye disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(97)04195-0
P698PubMed publication ID9250197

P2093author name stringR Klein
B E Klein
P2860cites workThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupQ27861088
Blind and partial sight registration in AvonQ33646943
Recent trends in the registration of blindness and partial sight in LeicestershireQ33646951
Primary care physicians' practice patterns and diabetic retinopathy. Current levels of careQ72996770
Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programmeQ73031887
Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1Q93559753
Retinopathy in young-onset diabetic patientsQ93613774
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyQ34720231
On the pathogenesis of diabetic retinopathy. A 1990 updateQ37341764
Ophthalmologic care for persons with diabetesQ39351759
Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima IndiansQ39622035
The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country townQ43545672
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathyQ43576480
Diabetic retinopathy in Mexican Americans and non-Hispanic whitesQ44037303
Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy?Q44172288
Risk factors for diabetic retinopathy: a population-based study in Rochester, MinnesotaQ45201955
Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factorsQ46630670
Ophthalmic examination among adults with diagnosed diabetes mellitus.Q50607546
The medical management of hyperglycemia over a 10-year period in people with diabetes.Q51010800
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in OklahomaQ51606566
Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood PressureQ51626229
Photocoagulation for Diabetic Macular EdemaQ60358385
Retinopathy in Pima Indians: Relationships to Glucose Level, Duration of Diabetes, Age at Diagnosis of Diabetes, and Age at Examination in a Population with a High Prevalence of Diabetes MellitusQ66884948
Cost-effectiveness of alternative methods for diabetic retinopathy screeningQ67574979
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathyQ67903084
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudateQ68018610
Genetic Marker Associations With Proliferative Retinopathy in Persons Diagnosed With Diabetes Before 30 yr of ageQ68169143
Is menarche associated with diabetic retinopathy?Q68550074
The relationship of puberty to diabetic retinopathyQ68706023
Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjectsQ69426099
New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulationQ69444229
Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?Q69553999
Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up studyQ69639684
Prevalence of diabetic complications in relation to risk factorsQ69640960
Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes StudyQ69749970
Association of cigarette smoking with diabetic retinopathyQ70212747
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 yearsQ70330511
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more yearsQ70330516
The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic RetinopathyQ70760004
Cost-effectiveness of detecting and treating diabetic retinopathyQ70880919
Relation of glycemic control to diabetic microvascular complications in diabetes mellitusQ70880944
Visual impairment in diabetesQ71307488
Prevalence of retinopathy and proteinuria in type 1 diabetics in IcelandQ71467811
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) StudyQ71717937
Diabetic retinopathy in NauruansQ71755916
Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research GroupQ71759102
Older-onset diabetes and lens opacities. The Beaver Dam Eye StudyQ71803736
Is cigarette smoking associated with diabetic retinopathy?Q71816165
Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye StudyQ72071872
Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research GroupQ72174601
Standards of medical care for patients with diabetes mellitus. American Diabetes AssociationQ72179968
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitusQ72340287
Retinopathy in African Americans and whites with insulin-dependent diabetes mellitusQ72855303
P433issue9072
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)197-204
P577publication date1997-07-01
P1433published inThe LancetQ939416
P1476titleDiabetic eye disease
P478volume350

Reverse relations

cites work (P2860)
Q40095379A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial.
Q37873482Anti-inflammatory therapy for diabetic retinopathy.
Q34800913Arginase in retinopathy
Q36385680Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design
Q74309367Danaparoid sodium in diabetic retinopathy
Q41776952Diabetic cataract-pathogenesis, epidemiology and treatment.
Q30771262Diabetic retinopathy after combined kidney-pancreas transplantation
Q82855470Genetics of diabetic retinopathy
Q43588806Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria
Q37911285Inflammation and diabetic retinal microvascular complications
Q34477134Laser refractive surgery in diabetic patients: a review of the literature
Q33605860Live imaging of primary ocular vasculature formation in zebrafish
Q74530411Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis
Q34516437Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy
Q34669214Printed educational messages aimed at family practitioners fail to increase retinal screening among their patients with diabetes: a pragmatic cluster randomized controlled trial [ISRCTN72772651].
Q34871834Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study
Q73370925Screening for diabetic retinopathy
Q35877208Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina
Q36412693The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes a
Q73252563The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus
Q34220590The potential of nanomedicine therapies to treat neovascular disease in the retina.
Q35589328The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study
Q28072125The role of Toll-like receptors in retinal ischemic diseases
Q34280300Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Q36929380Vascular endothelial growth factor in eye disease

Search more.